b12 injection with lidocaine Injections for Pain & Nerve Block Lidocaine 1% injectable -20 ml

Cells (2015) 4:52037

These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying

Caution is advised when administering this injection to children under 18 years of age

This has led to speculation that the peptide could be useful in probing pathways related to vascular repair and extracellular matrix turnover